Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesRemain bullish about performance overall in FY18: Strides Shasun

SHOW NAMES

Trending Topics

Sensex Live Ganesh Consumer IPO Atlanta Electricals IPO RailTel Corporation Shares GK Energy IPO GMP

business

Remain bullish about performance overall in FY18: Strides Shasun

Strides Shasun may receive approval for Lovaza generic, which has a market size of around USD 750-800 million in the United Sates and could make upto USD 200 million annually for the company. There has been a lot of buzz around pending application for Omega 3 which is the generic version of Lovaza, Shashank Sinha, MD & Group CEO of Strides Shasun told CNBC-TV18.

first published: Jul 17, 2017 12:33 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347